Medical Condition News

RSS

New electronic tattoo can measure activity of muscle and nerve cells

A new temporary "electronic tattoo" developed by Tel Aviv University that can measure the activity of muscle and nerve cells researchers is poised to revolutionize medicine, rehabilitation, and even business and marketing research.

12 Jul 2016

Aelan's researchers develop novel epigenetic biomarker for diagnosis of AD

Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).

12 Jul 2016

Pancreatic cysts increase overall risk of pancreatic cancer, study shows

A look back at more than half a million patient records has established that patients with pancreatic cysts have a significantly higher overall risk of pancreatic cancer compared to those without such cysts, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the journal of the American Society for Gastrointestinal Endoscopy.

12 Jul 2016

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Two Northwestern University neuroscientists have identified the neurochemical signal likely missing in Parkinson's disease by being the first to discover two distinctly different kinds of neurons that deliver dopamine to an important brain region responsible for both movement and learning/reward behavior.

12 Jul 2016

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.

12 Jul 2016

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson's disease or dementia with Lewy bodies.

12 Jul 2016

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.

11 Jul 2016

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.

11 Jul 2016

Prevalence of global diabetes has been vastly underestimated, say Monash researchers

A landmark paper led by Monash University with partners in the UK and US suggests there may be more than 100 million people with diabetes globally than previously thought.

11 Jul 2016

Scientists create new eye technology for detecting Alzheimer's before onset of symptoms

Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe - in the back of the eye - progression of the disease before the onset of symptoms.

11 Jul 2016

Metallic molecule offers real-time monitoring of amyloid plaques in patients with Alzheimer's

A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.

11 Jul 2016

Riverview Medical Center receives Lifeline Silver Achievement Award for dedication in cardiac care

Riverview Medical Center, part of Meridian CardioVascular Network, has received the Mission: Lifeline Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.

11 Jul 2016

Bayshore Community Hospital earns achievement award for appropriate treatment of STEMI patients

Bayshore Community Hospital, part of Meridian CardioVascular Network, has received the Mission: Lifeline Gold Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.

11 Jul 2016

Recellularized colon model helps identify cancer driver genes involved in CRC progression

Genetic mutations are a major cause of cancer, and tracking the role of each gene in cancer pathogenesis has long been an important tool in the fight against a disease that is expected to kill more than 1.6 million people this year.

11 Jul 2016

Scientists discover new mechanism by which TNF protects against intracellular pathogens

Tumour necrosis factor (TNF), a messenger substance in the immune system, plays an important role in triggering chronic inflammatory diseases. For this reason, TNF inhibitors are a standard form of treatment for patients with rheumatoid arthritis and certain inflammatory bowel diseases.

11 Jul 2016

Type 2 diabetes diagnosis may increase immediate risk of developing cancer

A new study indicates that individuals with diabetes may have an elevated risk of developing cancer before and immediately after a diabetes diagnosis. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for a better understanding of the link between diabetes and cancer.

11 Jul 2016

Gut bacteria can help predict susceptibility to rheumatoid arthritis

The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.

11 Jul 2016

Diversity of gut bacteria may affect brain health

The surprising and potentially wide-ranging effects that the levels and diversity of bacteria living in the gut have on overall human health, inflammation, and specifically brain health are the focus of a provocative interview with Dr. David Perlmutter in Alternative and Complementary Therapies, a journal from Mary Ann Liebert, Inc., publishers.

11 Jul 2016

New study identifies four subtypes of human insulin producing beta cells involved in diabetes

A new study led by nationally prominent stem cell scientist Markus Grompe, M.D., has determined the existence of at least four separate subtypes of human insulin producing beta cells that may be important in the understanding and treatment of diabetes. The findings were published online today in the journal Nature Communications.

11 Jul 2016

TBI with LOC linked to late-life neurodegeneration but not Alzheimer's disease

Traumatic brain injury (TBI) with a loss of consciousness (LOC) may be associated with later development of Parkinson's disease but not Alzheimer's disease or incident dementia, according to a study conducted at the Icahn School of Medicine at Mount Sinai and the University of Washington School of Medicine.

11 Jul 2016

Medical Condition News

New electronic tattoo can measure activity of muscle and nerve cells

Aelan's researchers develop novel epigenetic biomarker for diagnosis of AD

Pancreatic cysts increase overall risk of pancreatic cancer, study shows

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

FDA approves new ExAblate Neuro to treat patients with essential tremor

Prevalence of global diabetes has been vastly underestimated, say Monash researchers

Scientists create new eye technology for detecting Alzheimer's before onset of symptoms

Metallic molecule offers real-time monitoring of amyloid plaques in patients with Alzheimer's

Riverview Medical Center receives Lifeline Silver Achievement Award for dedication in cardiac care

Bayshore Community Hospital earns achievement award for appropriate treatment of STEMI patients

Recellularized colon model helps identify cancer driver genes involved in CRC progression

Scientists discover new mechanism by which TNF protects against intracellular pathogens

Type 2 diabetes diagnosis may increase immediate risk of developing cancer

Gut bacteria can help predict susceptibility to rheumatoid arthritis

Diversity of gut bacteria may affect brain health

New study identifies four subtypes of human insulin producing beta cells involved in diabetes

TBI with LOC linked to late-life neurodegeneration but not Alzheimer's disease

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News